Bret A. Campbell

Partner
Washington,  DC  U.S.A.
Phone202 862 2253

Peer Rating
 4.4/5.0
BV® Distinguished

Client Rating

Featured BV Peer Review Rated Lawyer IconFeatured BV Peer Review Rated Lawyer Icon
Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials Ratings & Reviews
 

Practice Areas

  • Anti-Money Laundering & Asset Forfeiture
  • Business Fraud & White Collar Defense
  • Commercial Bribery & FCPA
  • Corporate & Securities Litigation
  • Corporate Governance
  • Cyber and National Security
  • FCPA and International Anti-Bribery
  • False Claims Act
  • Financial Regulation
  • Government & Internal Investigations and Defense
  • Litigation
  • OFAC and Export Control
  • Pharmaceutical Regulation and Compliance
  • Securities Enforcement & Investigations
 
Contact InfoTelephone: 202 862 2253
Fax: 202 862 2400
http://www.cadwalader.com/professionals/bret-campbell
 
University Hobart and William Smith Colleges, B.A., with honors, 1989
 
Law SchoolVermont Law School, J.D., cum laude, 1994
 
Admitted1995, Massachusetts; 1996, New York and District of Columbia; U.S. District Court, District of Columbia
 
Biography

Bret Campbell is a partner in the White Collar Defense and Investigations Group in the Washington, D.C. office. Bret represents clients in a broad range of complex criminal, regulatory, and civil litigation matters involving international corruption and the Foreign Corrupt Practices Act, as well as securities, healthcare, accounting, and commercial fraud. He has extensive experience managing internal corporate investigations and cross-border criminal and regulatory matters, often in proceedings before the U.S. Department of Justice and the Securities and Exchange Commission. Other civil litigation experience includes representing clients in federal trial and appellate courts in matters involving contractual disputes, fraud, insurance coverage, employment issues, intellectual property rights and antitrust claims.

In addition to his litigation practice, Bret conducts FCPA and regulatory compliance due diligence reviews in connection with mergers, acquisitions, and other complex corporate transactions. He has directed numerous global due diligence reviews of proposed investments and business combinations in industries and jurisdictions presenting significant risks of corruption and fraud.

Bret also advises clients on corporate governance issues and on the implementation of compliance codes. He helps companies assess risks in their international operations, and counsels on the development and implementation of policies, procedures, and systems designed to prevent and detect potential violations of law. Bret regularly provides training on FCPA and related issues to his clients' legal, compliance and internal audit departments.

His clients include U.S. and foreign companies and individuals in the pharmaceutical, energy, medical device, telecommunications, financial services, defense, computer software, and aerospace industries. Recent engagements include litigation and internal investigations involving activities in Western and Eastern Europe (including Russia), Asia, Africa, the Middle East, Latin America and South America.

Bret writes and speaks frequently on regulatory, criminal law, and compliance issues, and has served as a faculty member of Seton Hall Law School's Healthcare Compliance Certification Program. He has spoken at events for the American Conference Institute, the Pharmaceutical Compliance Congress and Best Practices Forum, the Practising Law Institute, the Society of Corporate Compliance and Ethics, the Pharmaceutical Internal Audit Forum, and has co-chaired the American Conference Institute's annual conference on FCPA & Anti-Corruption for the Life Sciences Industry.

He received a B.A., with honors, in 1989 from Hobart College, and a J.D., cum laude, in 1994 from Vermont Law School. Bret is admitted to practice in the District of Columbia, the State of New York, and the U.S. District Court for the District of Columbia.

News

News Releases

Cadwalader Garners Multiple Burton Legal Writing Honors

Jun 12, 2012

Cadwalader Promotes Four to Partnership

Jan 05, 2010

Recent Press

Cadwalader Partner Bret Campbell on Being Caught Between a Great Wall and a Hard Place

Mar 03, 2014

Hedge Funds with SWF Clients Should Re-Jig Compliance Operations

Mar 28, 2011

Recognition

2012 Burton Awards for Legal Achievement

Jun 12, 2012

Resources

Clients & Friends Memos

First Amendment and Off-Label Promotion - Prosecute What I Do, Not What I Say

Apr 21, 2014

Ninth Circuit's Harkonen Decision Does Not Undermine Recent Second Circuit Precedent Establishing That Truthful Promotion Of Approved Drugs For Off-Label Use Is Protected By The First Amendment

Mar 22, 2013

Federal Court Finds that FDA Drug Approval is not Complete Defense to False Claims Act Allegation Involving On-Label Promotion

Feb 21, 2013

Second Circuit's Caronia Decision Striking Down On First Amendment Grounds The Criminal Conviction Of A Pharmaceutical Sales Representative For Off-Label Promotion Could Have Broad Implications

Jan 04, 2013

First Circuit Set to Weigh in on Significant Circuit Split Involving False Claims Act First to File Rule

Nov 23, 2012

U.S. Court of Appeals for D.C. Circuit Affirms Exclusion From Federal Health Care Programs Under Responsible Corporate Officer Doctrine

Aug 06, 2012

The Bribery Act 2010: Are You Ready?

Jun 30, 2011

SEC Launches FCPA Probe of Financial Services Industry's Interactions with Sovereign Wealth Funds

Mar 18, 2011

Articles

UK Issues Sentencing Guideline for Individuals Convicted of White-Collar Offenses

Aug 01, 2014

Caught Between a Great Wall and a Hard Place: Issues For U.S. Public Companies in Responding to Regulatory Requests for Chinese Data

Mar 31, 2014

U.K. Guidelines Emphasize Importance of Robust Programs

Mar 17, 2014

1st Circ. Set To Weigh In On FCA First-To-File Rule

Dec 04, 2012

Circuit Affirms Exclusion from Federal Health Care Programs under Responsible Corporate Officer Doctrine: Companies and Executives Beware of an Emboldened Department of Justice and HHS Office of Inspector General

Oct 01, 2012

SEC Launches FCPA Probe of Financial Services Industry's Interactions With Sovereign Wealth Funds

Aug 01, 2011

Events

FCPA in 2014 & Beyond

Sep 10, 2014

Seton Hall Law School West Coast Biotech Compliance Conference

Sep 08, 2014

9th Annual Homeland Security Law Institute

Aug 21, 2014

ACI's 8th Advanced Forum on FCPA & Anti-Corruption for the Life Sciences Industry

Apr 28, 2014

The American Bar Association's 28th Annual National Institute on White Collar Crime

Mar 05, 2014

Seton Hall Law School Healthcare Compliance: FCPA

Oct 14, 2013

Events In The Nation's Capital Continue To Impact Enforcement And Compliance Efforts

Jul 09, 2013

Forum on Anti-Corruption

Jun 25, 2013

The Global Anti-Corruption Congress

Jun 18, 2013

Healthcare Compliance Program: FCPA

Jun 10, 2013

FCPA and Anti-Corruption for the Life Sciences Industry

May 14, 2013

Corporate Compliance & Regulatory Update Conference 2013

Apr 29, 2013

FCPA and the Life Sciences Industry

Oct 10, 2012

Newsletter

FCPA Advisor

Canadian Court Hands Down First Prison Sentence Under Corruption of Foreign Public Officials Act

Jun 03, 2014

Will Independent Directors Be on the Hook for Failure of Internal Controls in FCPA Cases?

Jul 15, 2013

Allianz To Pay $12.3M To Settle SEC's Bribery Allegations

Dec 19, 2012

DOJ and SEC Issue FCPA Guidance

Nov 19, 2012

FCPA Allegations Involving Customs Clearance in Kazakhstan

Jun 11, 2012

Lindsey Manufacturing's Conviction Overturned

Dec 05, 2011

With Publication of Final Guidance, UK Bribery Act to Go Into Effect on July 1, 2011

Apr 15, 2011

U.K. Ministry of Justice Further Delays Implementation of Bribery Act

Feb 03, 2011

New Compliance Criteria Set in Sentencing Guidelines

Nov 30, 2010

ABB Entities Resolve FCPA Investigation

Nov 30, 2010

Panalpina, Shell, Four Oil Services Companies Settle FCPA Charges

Nov 30, 2010

Intermediaries Indicted for Involvement in Scheme to Bribe Mexican Officials

Sep 29, 2010

U.K. Ministry of Justice Releases Guidance on Bribery Act

Sep 29, 2010

Department of Justice Issues FCPA Opinion Procedure Release on the Definition of the term Foreign Official

Sep 03, 2010

Alliance One and Universal Corp Settle DOJ, SEC Charges; Former Country Manager of Alliance One Pleads Guilty

Aug 16, 2010

Giffen Pleads Guilty to Misdemeanor Tax Violation 7 Years After FCPA-Indictment; His Merchant Bank Pleads Guilty to FCPA Felony

Aug 16, 2010

Department of Justice Issues Second FCPA Opinion Procedure Release for 2010 Regarding Government Compelled Grants and Due Diligence

Aug 02, 2010

GE Agrees to Pay $23.4 Million to SEC to Settle FCPA Charges

Jul 29, 2010

Implementation of U.K. Bribery Act Delayed Until April 2011

Jul 26, 2010

ENI and Snamprogetti Settle Criminal and Civil Charges Related to the Bonny Island Project in Nigeria; JGC Corporation Discloses Settlement Discussions

Jul 15, 2010

Breuer Cautiously Approaches Costly FCPA Cases

Jul 02, 2010

Financial Reform Bill Compensates Whistleblowers Assisting the SEC

Jul 02, 2010

Technip Enters into DPA with DOJ, Pays $338 Million Settlement

Jul 02, 2010

Department of Justice Guidance on Company Disputes with Corporate Monitors

Jul 02, 2010

First DOJ FCPA Opinion Procedure Release in 2010

Jul 02, 2010

SEC Enforcement Advisor

SEC Announces Largest Ever Whistleblower Award, Awards $30 Million to Foreign Whistleblower

Oct 01, 2014

Second Circuit Holds that Anti-Retaliation Provisions of Dodd Frank Act Have No Extraterritorial Application

Aug 20, 2014

Gatekeepers In the Enforcement Spotlight

May 22, 2014

SEC Announces Second Set of Whistleblower Awards

Jul 01, 2013

The SEC's New Policy on Seeking Admissions in Settlements

Jun 28, 2013

White Collar Defense and Investigations Advisor

AML Guidance Issued for Banks Seeking to Service Marijuana-Related Businesses

Feb 27, 2014

SEC Issues Guidance on Conflict Minerals Rule

Jun 10, 2013

U.S. and Chinese Regulators Sign Historic Memorandum of Understanding Regarding Enforcement Cooperation

May 31, 2013

Southern District of New York Orders Chevron CEO and General Counsel to Testify in RICO Suit Related to $18 Billion Ecuadorian Judgment

May 28, 2013

European Union Pending Legislation Requiring Additional Transparency from Extractive Industries

May 20, 2013

A Brief Primer for Corporate Social Media Disclosures in Light of the SEC's Recent Guidance on Regulation FD

Apr 08, 2013

The Dodd-Frank Whistleblower Program: An Analysis of the SEC's Second Annual Report, Best Practices for Dealing with Whistleblowers, and Recent Cases Interpreting the Scope of the Anti-Retaliation Provisions of the Dodd-Frank Act

Dec 10, 2012

SEC Issues Resource Extraction Rule

Sep 21, 2012

SEC Issues Conflict Minerals Rule

Aug 29, 2012

The Evolving Obligations of Public Companies to Disclose Cyber-Intrusions

Jul 09, 2012

Justice Department Establishes Residential Mortgage-Backed Securities Working Group

Jan 31, 2012

The Dodd-Frank Whistleblower Provisions: Considerations for Effectively Preparing for and Responding to Whistleblowers

May 26, 2011

FinCEN Issues Final Rule on Foreign Bank Account Reporting (FBAR)

Mar 01, 2011

European Court of Justice Declares Corporate Communications With In-House Counsel Not Protected by Legal Professional Privilege

Sep 17, 2010

Barclays Bank PLC Forfeits $298 Million for Violations of U.S. Economic Sanctions; U.S. Judge Questions Use of DPA, Lack of Individuals Prosecuted

Aug 19, 2010

The Comprehensive Iran Sanctions, Accountability and Divestment Act of 2010

Jul 26, 2010

New Whistleblower Compensation Enacted for Securities and FCPA Disclosures

Jul 26, 2010

SEC and Goldman Sachs Agree to Settle Historic Market-Crisis Enforcement Action

Jul 19, 2010

Supreme Court Limits Application of the Honest Services Fraud Statute

Jul 15, 2010

 
ISLN909736116
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

First Amendment and Off-Label Promotion - Prosecute What I Do, Not What I Say
Bret A. Campbell,Jason Jurgens,Adam S. Lurie,Brian T. McGovern,Martin L. Seidel, April 23, 2014
On December 3, 2012, the United States Court of Appeals for the Second Circuit vacated the conviction of Alfred Caronia (“Caronia”), who had been tried and convicted of participating in an unlawful conspiracy to introduce a misbranded drug into interstate commerce in violation of the...


View Ratings & Reviews
Profile Visibility
#1,231 in weekly profile views out of 50,076 lawyers in Washington, District of Columbia
#46,159 in weekly profile views out of 1,571,845 total lawyers Overall

Office Information

Bret A. Campbell

700 Sixth Street, N.W.
WashingtonDC 20001




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now